Brian P. Mckeon - Feb 7, 2024 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Signature
/s/ Lily J. Lu, Attorney-in-Fact for Brian P. McKeon
Stock symbol
IDXX
Transactions as of
Feb 7, 2024
Transactions value $
-$9,993,013
Form type
4
Date filed
2/9/2024, 05:01 PM
Previous filing
Aug 8, 2023
Next filing
Feb 13, 2024

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -23.3K -100% 0 Feb 7, 2024 Common Stock 23.3K $141.60 Direct F11, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 25.247 shares purchased under the Issuer Employee Stock Purchase Plan on September 29, 2023 and December 29, 2023.
F2 Represents the weighted average price of the shares sold ranging from a low of $563.48 to a high of $564.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F3 Represents the weighted average price of the shares sold ranging from a low of $564.63 to a high of $565.50 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F4 Represents the weighted average price of the shares sold ranging from a low of $565.89 to a high of $566.84 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F5 Represents the weighted average price of the shares sold ranging from a low of $566.92 to a high of $567.86 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F6 Represents the weighted average price of the shares sold ranging from a low of $568.33 to a high of $569.28 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F7 Represents the weighted average price of the shares sold ranging from a low of $569.34 to a high of $570.34 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F8 Represents the weighted average price of the shares sold ranging from a low of $570.345 to a high of $571.34 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F9 Represents the weighted average price of the shares sold ranging from a low of $571.36 to a high of $572.33 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F10 Represents the weighted average price of the shares sold ranging from a low of $572.42 to a high of $573.09 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F11 Grant of option to buy shares of Issuer common stock that vested in five annual installments beginning February 14, 2018.
F12 Not applicable.